ABOUT THE PRODUCT
A novel therapeutic approach targeting Myc, a key driver of cancer development. These degraders eliminate Myc from cancer cells and the surrounding microenvironment, unleashing the immune system against notoriously hard-to-treat cancers.
Information is owner-confirmed
Last updated 4 months ago
Price range
Other products/services from Ten63 Therapeutics
BEYOND Platform
Biotechnology
N/A
Ten63 Therapeutics
United States (US)